

From
the Kalyto perpective, NPWT technology starts with the
dressing. The revolutionary Kalypto 8 oz. pump technology is
made
possible by their proprietary dressing. This dressing begins with an
FDA approved wound contact layer made of Silverlon, a minimally
adherent, "plated" medical nylon material infused with silver (Ag) ions
that have an bactericidal effect. The next layer includes a
two-fiber, non-woven exudate collection pad made up of a hydrophilic,
water attracting fiber that wicks fluids into a super absorbent,
molecularly bonding inner pad. The pad swells as fluid is
absorbed
and will not occlude within the capacity of the dressing. Periwound
masceration is not an issue because the pad is protected by a
hydrophobic (water resistant) Gore membrane, similar to that found in
vascular grafts and dialysis filters, which secures the trapped fluid
and bacteria infused exudate securely within the dressing. The
collection pad is laminated to a non-woven, semi-occlusive polyurethane
film for strength and conformability. The Kalypto system is completed
by a hydrogel gasket surrounding the periphery of the
wound, which flows into the ridges of the healthy skin,
preventing any adhesive leaks that might compromise the suction of the
pump.
Three windows contained within the exterior bandage
monitor the exudate traveling to the pressure port connecting the wound
dressing to the suction pump via a proprietary "quick connect
pigtail" and tubing. This design allows for application of compression
wraps, offloading, and other therapeutic interventions, as determined
by the clinican. This truly portable, 8 oz pump operates on three AA
alkaline batteries, offering pressure settings between 40-125mmHg with
continuous and intermittent pressure modes. No exudate travels through
the tubing, which eliminates the need for canister storage and
inherent disposal issues. Initial dressing application and
subsequent changes require less than five minutes time to complete,
with bacteria safely and hygenically contained within
the interior
dressing.
MANAGING
EXUDATE
Choice
of dressing to manage exudate is important. A number of properties can
be considered in dressing choice such as the desired moisture balance
and the dressing’s ability to assist healing or prevent wound
deterioration. While many dressings will absorb exudate or manage
exudate through evaporation, other considerations for dressing
characteristics include:
Retention:
Dressings that form a cohesive gel tend to maintain their structure
during use and may reduce the risk of periwound maceration, by
preventing fluid from tracking through the dressing.
Sequestration:
The ability, demonstrated in vitro, of some dressings' to trap bacteria
and components of exudate within the dressing.
INFECTION
CONTROL
All
wounds, even postoperative wounds, are colonized by a variety of
aerobic and anaerobic bacteria. However, the presence of bacteria in a
wound is not inherently harmful – infection only occurs when the
bioburden exceeds the level manageable by the host. Wound bioburden
refers to the presence of bacteria in the wound competing for a limited
supply of oxygen and nutrients, which creates a burden on the
wound-healing process. Bioburden is more than just a quantitative
assessment of the number of bacteria present in the wound; diversity,
virulence, and interaction of organisms are also key factors of the
negative impact of micro-organisms on the wound. Toxins released from
certain bacteria, such as Pseudomonas aeruginosa, are known to affect
progression toward healing. When should NPWT be
discontinued?
When
the treatment goal is met, NPWT should be stopped. It has been
recommended that a 50% improvement in wound size over four weeks is a
good indication that the therapy is working and that the wound will
heal. In addition, careful attention should be paid to the development
of worsening infection, necrotic tissue, and uncontrolled bleeding with
the use of NPWT. In some cases, NPWT can be used until wound closure,
although in most cases, it is used until the wound is filled with good
granulation tissue and ready for standard wound therapy, skin graft, or
flap. For more information on Kalypto Medical Devices, visit www.kalyptomedical.com.
|